Fig. 4From: Shifts in subsets of CD8+ T-cells as evidence of immunosenescence in patients with cancers affecting the lungs: an observational case-control studyThe proportions of CD28+CD57-, CD28+CD57+, CD28-CD57- and CD28-CD57+ cells from CD8+ T-cells, among lung cancer patients and controls (a–d) and according to cancer disease stages (e–h), at baseline (T0), 1 month (T1), 3 months (T3), and 6 months (T6)Back to article page